Does ALEMTUZUMAB Cause Lymphopenia? 440 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 440 reports of Lymphopenia have been filed in association with ALEMTUZUMAB (Campath). This represents 3.1% of all adverse event reports for ALEMTUZUMAB.
440
Reports of Lymphopenia with ALEMTUZUMAB
3.1%
of all ALEMTUZUMAB reports
33
Deaths
183
Hospitalizations
How Dangerous Is Lymphopenia From ALEMTUZUMAB?
Of the 440 reports, 33 (7.5%) resulted in death, 183 (41.6%) required hospitalization, and 66 (15.0%) were considered life-threatening.
Is Lymphopenia Listed in the Official Label?
Yes, Lymphopenia is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Lymphopenia?
FINGOLIMOD (1,515)
CYCLOPHOSPHAMIDE (952)
RITUXIMAB (932)
DEXAMETHASONE (814)
PREDNISONE (788)
DIMETHYL (598)
METHOTREXATE (549)
PREDNISOLONE (465)
TACROLIMUS (456)
MYCOPHENOLATE MOFETIL (453)
Which ALEMTUZUMAB Alternatives Have Lower Lymphopenia Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET